AASK
2002
African American Study of Kidney Disease and Hypertension
In 1,094 Black patients with hypertensive nephrosclerosis, ramipril slowed kidney-disease progression compared with amlodipine or metoprolol.
Result
Primary endpoint: Composite of GFR decline, ESRD or death
Ramipril vs amlodipine 38% risk reduction in clinical composite (95% CI 14–56%, p=0.004).
- Subtopic
- RAAS blockade
- Design
- 3×2 factorial RCT
- Relevance
- Important: one of several pillars.
- Cited in
- KDIGO 2021 BP in CKD
- Source
- Wright JT, et al. JAMA. 2002;288(19):2421-2431.doi 10.1001/jama.288.19.2421
Discussion & critique
The only major CKD trial conducted entirely in a Black population; informed the later blood-pressure-target debate.